Profile
Amy Franke is Vice President-Clinical Operations at Shattuck Labs, Inc. since 2022.
Former roles include Senior Director-Strategy & Planning at Labcorp Drug Development, Inc., Vice President-Clinical Operations at NervGen Pharma Corp., and Vice President-Clinical Operations at Aravive, Inc. Education includes undergraduate studies at the University of Michigan and graduate studies at the University of Pennsylvania Medical Center.
Amy Franke active positions
| Companies | Position | Start |
|---|---|---|
| SHATTUCK LABS, INC. | Chief Tech/Sci/R&D Officer | 2022-09-30 |
Former positions of Amy Franke
| Companies | Position | End |
|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 2022-07-31 |
| COVANCE INC. | Corporate Officer/Principal | - |
| NERVGEN PHARMA CORP. | Chief Tech/Sci/R&D Officer | - |
Education of Amy Franke
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shattuck Labs, Inc.
Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
NervGen Pharma Corp.
NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
- Stock Market
- Insiders
- Amy Franke
















